Charting a course for the management of long COVID
- PMID: 34416190
- PMCID: PMC8372495
- DOI: 10.1016/S2213-2600(21)00314-3
Charting a course for the management of long COVID
Conflict of interest statement
RB has received research funding from the Health Research Council of New Zealand through his institution, research funding from AstraZeneca, Genentech, and Fisher & Paykel Healthcare, and honoraria from AstraZeneca, Cipla, Theravance, and Avillion; he is chair of an asthma guidelines group for the Asthma and Respiratory Foundation NZ. NK and TH declare no competing interests.
Comment on
-
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.Lancet Respir Med. 2021 Dec;9(12):1467-1478. doi: 10.1016/S2213-2600(21)00286-1. Epub 2021 Aug 17. Lancet Respir Med. 2021. PMID: 34416191 Free PMC article. Review.
References
-
- Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259–264. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
